Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration.

Cancers (Basel) · 2019 · PMC6521049 · PMID 30987208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Here, we performed a proteomic study, which revealed consistent and highly significant downregulation of the intermediate protein vimentin after treatment of GBM cells with LiCl, and the indirubin derivative 6-bromo-indirubin-3-oxime (BIO).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.